ESRRB and cancer: Recent studies show that polyphenolic compounds such as quercetin, kaempferol, broussochalcone and resveratrol bind the orphan nuclear receptor NR4A1, and in cancer cell models these compounds act as NR4A1 antagonists [33,34,35].